Sign in
4

Changes in Ownership

Lexaria Bioscience Corp. Filed Acc 0001312326-19-000003

Director acquired 110,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Baxter Nicholas W · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2019-12-20 Exercise or conversion : show line 1 in the form +110,000 $0.10 $11,000 330,000 D

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2019-12-20 Exercise or conversion : show line 2 in the form Stock Options −110,000 $0.10 $11,000 150,000 D
Loading xslF345X03/primary_doc.xml…